Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Steven Rosenberg

Concepts (590)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Neoplasm
56
2025
308
13.620
 Why?
Lymphocytes, Tumor-Infiltrating
61
2025
207
13.410
 Why?
Receptors, Antigen, T-Cell
55
2024
704
11.300
 Why?
Immunotherapy, Adoptive
53
2024
295
11.070
 Why?
T-Lymphocytes
47
2024
1933
7.620
 Why?
Melanoma
49
2024
729
7.350
 Why?
Neoplasms
35
2025
2449
5.750
 Why?
CD8-Positive T-Lymphocytes
26
2023
857
4.040
 Why?
Gastrointestinal Neoplasms
7
2020
72
3.720
 Why?
Autism Spectrum Disorder
22
2024
386
3.650
 Why?
Immunotherapy
16
2025
592
3.330
 Why?
Adoptive Transfer
18
2024
218
2.810
 Why?
Proto-Oncogene Proteins p21(ras)
8
2022
259
2.740
 Why?
Mutation
32
2025
3710
2.500
 Why?
Developmental Disabilities
13
2023
261
2.500
 Why?
Cancer Vaccines
8
2021
164
2.180
 Why?
Antigens, CD19
9
2022
114
2.110
 Why?
CD4-Positive T-Lymphocytes
12
2022
1056
1.980
 Why?
Skin Neoplasms
13
2020
824
1.870
 Why?
Neoplasm Metastasis
18
2024
610
1.860
 Why?
Autistic Disorder
8
2024
189
1.800
 Why?
Programmed Cell Death 1 Receptor
8
2019
232
1.780
 Why?
Interleukin-2
6
2020
437
1.660
 Why?
Humans
191
2025
129271
1.570
 Why?
ras Proteins
4
2021
144
1.480
 Why?
Colorectal Neoplasms
5
2025
752
1.450
 Why?
Neoplasm Proteins
7
2019
422
1.360
 Why?
Tumor Suppressor Protein p53
6
2022
509
1.320
 Why?
High-Throughput Nucleotide Sequencing
6
2025
485
1.290
 Why?
Epitopes, T-Lymphocyte
9
2021
186
1.230
 Why?
Eligibility Determination
3
2014
63
1.230
 Why?
Genetic Therapy
8
2022
288
1.190
 Why?
Lymphoma, B-Cell
4
2020
105
1.120
 Why?
Membrane Proteins
9
2019
1117
1.120
 Why?
Female
99
2025
68556
1.080
 Why?
Glioblastoma
2
2021
322
1.070
 Why?
Proto-Oncogene Proteins B-raf
4
2019
209
1.050
 Why?
Motor Skills Disorders
4
2016
26
1.020
 Why?
Child Development
7
2024
457
0.980
 Why?
Transcriptome
4
2022
874
0.940
 Why?
Male
83
2025
63517
0.920
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2017
112
0.910
 Why?
Genetic Engineering
6
2016
86
0.910
 Why?
HLA-A2 Antigen
11
2020
48
0.890
 Why?
Middle Aged
53
2025
31091
0.890
 Why?
Cell Line, Tumor
26
2021
3202
0.880
 Why?
Gene Expression Regulation, Neoplastic
7
2019
1344
0.880
 Why?
Precision Medicine
3
2015
386
0.830
 Why?
Flow Cytometry
9
2018
1155
0.830
 Why?
Ovarian Neoplasms
2
2019
489
0.820
 Why?
T-Lymphocyte Subsets
5
2019
412
0.800
 Why?
Tumor Microenvironment
2
2019
631
0.790
 Why?
Medicare Part C
2
2013
28
0.780
 Why?
Single-Cell Analysis
3
2022
275
0.760
 Why?
Coronary Artery Disease
5
2017
679
0.760
 Why?
Cell Separation
4
2019
316
0.750
 Why?
HLA-DP beta-Chains
3
2019
84
0.720
 Why?
Adult
45
2024
35497
0.720
 Why?
Interleukin-12
3
2020
118
0.710
 Why?
Receptors, Antigen
3
2015
15
0.700
 Why?
Hematopoietic Stem Cell Transplantation
3
2022
572
0.680
 Why?
Cognition Disorders
2
2016
505
0.670
 Why?
HLA-A Antigens
2
2021
53
0.670
 Why?
Receptors, Antigen, T-Cell, alpha-beta
4
2020
336
0.660
 Why?
Antigen Presentation
8
2020
207
0.660
 Why?
Retroviridae
2
2022
99
0.650
 Why?
Mutation, Missense
2
2020
317
0.640
 Why?
Interleukin-15
2
2017
82
0.640
 Why?
Colonic Neoplasms
2
2019
242
0.630
 Why?
Mucin-4
1
2019
4
0.630
 Why?
Smad5 Protein
1
2019
8
0.630
 Why?
Child, Preschool
29
2024
10459
0.630
 Why?
Aged
32
2025
22032
0.630
 Why?
Exome
7
2016
220
0.620
 Why?
Temperament
1
2019
47
0.620
 Why?
Cholangiocarcinoma
2
2023
77
0.620
 Why?
Lymphocyte Depletion
2
2016
131
0.610
 Why?
Immunity, Cellular
1
2020
265
0.610
 Why?
Bile Duct Neoplasms
2
2023
99
0.600
 Why?
T-Lymphocytes, Regulatory
2
2019
373
0.600
 Why?
Sequence Analysis, DNA
2
2021
776
0.590
 Why?
ErbB Receptors
2
2019
605
0.580
 Why?
RNA, Messenger
3
2020
2703
0.550
 Why?
Disease Susceptibility
1
2019
333
0.550
 Why?
Family Characteristics
2
2018
178
0.550
 Why?
Genetic Vectors
5
2022
312
0.550
 Why?
Antigens
1
2019
356
0.540
 Why?
History, 20th Century
4
2025
291
0.540
 Why?
Child Behavior
1
2019
235
0.530
 Why?
Social Behavior
2
2023
288
0.520
 Why?
History, 21st Century
3
2025
183
0.520
 Why?
Disabled Children
2
2014
68
0.520
 Why?
Myocardial Perfusion Imaging
2
2013
36
0.520
 Why?
Awards and Prizes
1
2017
63
0.510
 Why?
Communication
2
2023
836
0.510
 Why?
Transposases
1
2016
16
0.510
 Why?
Cell Engineering
1
2016
9
0.510
 Why?
Gene Expression Profiling
8
2019
1688
0.500
 Why?
Lymphoma
1
2017
196
0.500
 Why?
Self-Injurious Behavior
4
2018
120
0.490
 Why?
Psychotherapy
1
2017
157
0.490
 Why?
Bile Ducts, Intrahepatic
2
2023
65
0.490
 Why?
Cell Cycle Checkpoints
1
2016
95
0.490
 Why?
Immunologic Memory
5
2024
349
0.480
 Why?
Surveys and Questionnaires
9
2024
5384
0.460
 Why?
Breast Neoplasms
3
2022
2140
0.440
 Why?
Lymphocytes
1
2016
378
0.430
 Why?
T-Cell Antigen Receptor Specificity
7
2020
51
0.430
 Why?
Lymphocyte Transfusion
1
2013
20
0.430
 Why?
Lymphocyte Activation
10
2020
1109
0.430
 Why?
Indoles
1
2016
384
0.430
 Why?
Sentinel Lymph Node Biopsy
1
2014
107
0.430
 Why?
Th1 Cells
1
2014
137
0.420
 Why?
Vidarabine
4
2017
30
0.420
 Why?
Animals
29
2024
35309
0.420
 Why?
Plaque, Atherosclerotic
1
2014
55
0.420
 Why?
Leukemia
2
2016
229
0.420
 Why?
Histocompatibility Antigens Class I
5
2021
200
0.410
 Why?
Child
22
2024
20785
0.410
 Why?
Lymph Node Excision
1
2014
164
0.410
 Why?
Transplantation Conditioning
4
2019
166
0.400
 Why?
Sulfonamides
1
2016
495
0.400
 Why?
Cyclophosphamide
4
2017
232
0.400
 Why?
Melanoma, Experimental
4
2020
107
0.390
 Why?
Stem Cell Transplantation
1
2013
164
0.390
 Why?
Cell- and Tissue-Based Therapy
3
2019
76
0.390
 Why?
Mice
21
2024
16915
0.390
 Why?
Transfection
1
2014
915
0.380
 Why?
Genes, T-Cell Receptor
3
2022
9
0.380
 Why?
Antibodies, Monoclonal
3
2017
1367
0.370
 Why?
Adaptor Proteins, Signal Transducing
1
2014
399
0.360
 Why?
Melanoma-Specific Antigens
3
2016
5
0.360
 Why?
Biomarkers, Tumor
6
2019
1173
0.360
 Why?
Treatment Outcome
15
2021
10202
0.350
 Why?
United States
16
2025
13828
0.350
 Why?
Case-Control Studies
13
2024
3377
0.350
 Why?
Lung Neoplasms
3
2022
2342
0.350
 Why?
Neoplasms, Second Primary
2
2022
106
0.350
 Why?
Transplantation, Autologous
3
2022
211
0.340
 Why?
Coculture Techniques
3
2021
223
0.340
 Why?
Receptor, ErbB-2
4
2016
326
0.340
 Why?
Papillomavirus Infections
3
2018
297
0.340
 Why?
Papillomaviridae
3
2019
114
0.330
 Why?
Kidney Neoplasms
1
2014
348
0.330
 Why?
Medicaid
1
2014
431
0.330
 Why?
gp100 Melanoma Antigen
5
2016
8
0.330
 Why?
Infant
11
2017
8975
0.330
 Why?
Child Development Disorders, Pervasive
2
2024
61
0.330
 Why?
Coronary Angiography
4
2017
305
0.320
 Why?
Transduction, Genetic
4
2019
128
0.310
 Why?
Peptides
4
2020
923
0.310
 Why?
Combined Modality Therapy
5
2021
1199
0.300
 Why?
Human papillomavirus 16
3
2018
34
0.300
 Why?
Phenotype
6
2024
3074
0.300
 Why?
Gene Expression
6
2016
1466
0.290
 Why?
Repressor Proteins
3
2017
406
0.290
 Why?
Intellectual Disability
3
2024
154
0.290
 Why?
Antigens, Differentiation, T-Lymphocyte
2
2020
88
0.290
 Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
3
2017
26
0.280
 Why?
Prevalence
8
2018
2554
0.280
 Why?
Cells, Cultured
8
2021
4077
0.280
 Why?
Algorithms
3
2015
1613
0.280
 Why?
Prospective Studies
6
2023
7123
0.270
 Why?
Carcinoma, Squamous Cell
3
2017
625
0.270
 Why?
Neoplasm Staging
5
2018
1290
0.270
 Why?
Dendritic Cells
4
2019
479
0.270
 Why?
Tomography, X-Ray Computed
6
2018
2515
0.270
 Why?
Uterine Cervical Neoplasms
4
2018
230
0.270
 Why?
Young Adult
13
2020
12392
0.260
 Why?
Oncogene Proteins, Viral
2
2017
22
0.260
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2014
1556
0.260
 Why?
Lymphocyte Count
2
2016
148
0.260
 Why?
Antigens, CD
3
2020
489
0.260
 Why?
Cell Proliferation
8
2019
2375
0.260
 Why?
CD8 Antigens
2
2018
76
0.250
 Why?
Carcinoma
2
2018
215
0.240
 Why?
Brain Neoplasms
4
2018
1143
0.240
 Why?
National Cancer Institute (U.S.)
1
2025
43
0.240
 Why?
Tumor Cells, Cultured
5
2018
942
0.240
 Why?
Whole-Body Irradiation
2
2016
76
0.230
 Why?
Socioeconomic Factors
3
2018
1209
0.230
 Why?
Longitudinal Studies
5
2016
2716
0.230
 Why?
Adolescent
13
2023
20315
0.220
 Why?
DNA Transposable Elements
2
2016
118
0.220
 Why?
T-Lymphocytes, Cytotoxic
2
2015
169
0.220
 Why?
Sensitivity and Specificity
3
2018
1839
0.220
 Why?
Pilot Projects
4
2019
1584
0.220
 Why?
Jaundice, Neonatal
1
2023
9
0.220
 Why?
Immunohistochemistry
4
2016
1691
0.210
 Why?
Disability Evaluation
3
2014
284
0.210
 Why?
Leukocytes, Mononuclear
3
2015
545
0.210
 Why?
Infant, Very Low Birth Weight
2
2014
67
0.210
 Why?
Problem Behavior
2
2022
92
0.210
 Why?
Protein Engineering
2
2014
106
0.210
 Why?
Parks, Recreational
1
2022
10
0.200
 Why?
Proto-Oncogene Proteins
2
2017
635
0.200
 Why?
Constriction, Pathologic
2
2014
226
0.200
 Why?
Time-to-Treatment
1
2024
179
0.200
 Why?
Occupational Therapy
2
2014
85
0.190
 Why?
Multiple Myeloma
1
2023
125
0.190
 Why?
DNA-Binding Proteins
3
2019
1446
0.190
 Why?
Proteasome Endopeptidase Complex
2
2020
148
0.190
 Why?
Adaptation, Psychological
2
2024
614
0.190
 Why?
HEK293 Cells
5
2017
696
0.190
 Why?
Burkitt Lymphoma
1
2022
56
0.190
 Why?
Amino Acid Sequence
4
2020
2056
0.190
 Why?
Sex Factors
4
2017
1965
0.190
 Why?
Clone Cells
2
2019
262
0.190
 Why?
Oncogenes
2
2020
112
0.180
 Why?
Genes, Tumor Suppressor
2
2019
86
0.180
 Why?
Pancreatic Neoplasms
2
2022
881
0.180
 Why?
Genes, T-Cell Receptor alpha
1
2021
12
0.180
 Why?
Apyrase
1
2020
16
0.180
 Why?
Demography
3
2018
279
0.180
 Why?
Gene Expression Regulation
3
2019
2537
0.180
 Why?
Cytokines
6
2022
2013
0.180
 Why?
Lectins, C-Type
1
2020
71
0.170
 Why?
Epitope Mapping
2
2018
57
0.170
 Why?
Oncolytic Virotherapy
1
2020
13
0.170
 Why?
HLA Antigens
2
2021
234
0.170
 Why?
MART-1 Antigen
3
2014
12
0.170
 Why?
Physical Therapy Modalities
2
2014
291
0.170
 Why?
Psychotropic Drugs
1
2021
69
0.170
 Why?
Lymphatic Metastasis
2
2019
320
0.170
 Why?
Mice, Mutant Strains
1
2020
297
0.170
 Why?
Models, Immunological
1
2020
95
0.170
 Why?
Premature Birth
1
2023
314
0.170
 Why?
Drug Utilization
1
2021
171
0.170
 Why?
Virus Replication
1
2022
450
0.170
 Why?
Protein Binding
8
2020
2120
0.170
 Why?
HLA-C Antigens
2
2020
35
0.170
 Why?
Metastasectomy
2
2017
19
0.160
 Why?
Remission Induction
5
2020
271
0.160
 Why?
Neoplasm Recurrence, Local
2
2017
958
0.160
 Why?
Gene Regulatory Networks
1
2022
280
0.160
 Why?
Amino Acid Substitution
1
2020
282
0.160
 Why?
Age Factors
3
2024
3140
0.160
 Why?
Cysteine
1
2020
195
0.160
 Why?
Practice Patterns, Physicians'
2
2021
1267
0.150
 Why?
Gestational Age
2
2024
874
0.150
 Why?
Neoplasms, Glandular and Epithelial
1
2019
35
0.150
 Why?
Alcohol Oxidoreductases
1
2019
60
0.150
 Why?
Referral and Consultation
4
2023
727
0.150
 Why?
Follow-Up Studies
6
2020
4887
0.150
 Why?
Area Under Curve
3
2014
304
0.150
 Why?
Cell Line
4
2022
2779
0.150
 Why?
Behavior Therapy
1
2021
241
0.150
 Why?
Cohort Studies
6
2016
5409
0.150
 Why?
Neoplastic Cells, Circulating
1
2019
70
0.150
 Why?
B-Lymphocytes
3
2020
815
0.150
 Why?
Medical Oncology
1
2020
270
0.150
 Why?
RGS Proteins
1
2018
16
0.150
 Why?
Smoking
2
2018
1499
0.150
 Why?
Trees
1
2018
69
0.150
 Why?
Ubiquitin Thiolesterase
1
2018
42
0.140
 Why?
Mothers
1
2024
730
0.140
 Why?
Forkhead Transcription Factors
1
2019
184
0.140
 Why?
Education, Special
1
2017
24
0.140
 Why?
Parents
4
2022
1309
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
77
0.140
 Why?
Hematologic Neoplasms
1
2019
140
0.140
 Why?
Psychometrics
2
2019
691
0.140
 Why?
Uveal Neoplasms
1
2017
10
0.140
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 14
1
2017
4
0.140
 Why?
Self-Examination
1
2017
2
0.140
 Why?
ROC Curve
3
2013
503
0.140
 Why?
Recombinant Fusion Proteins
3
2015
648
0.140
 Why?
Societies, Scientific
1
2017
45
0.140
 Why?
Signal Transduction
5
2019
4926
0.140
 Why?
Interferon-gamma
5
2020
772
0.140
 Why?
Population Surveillance
2
2017
438
0.140
 Why?
Maternal Age
1
2017
124
0.140
 Why?
Immunologic Surveillance
1
2017
26
0.130
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2017
169
0.130
 Why?
Tissue and Organ Procurement
1
2020
288
0.130
 Why?
Administration, Intravenous
1
2017
141
0.130
 Why?
Carcinogenesis
1
2018
213
0.130
 Why?
Prognosis
5
2020
3773
0.130
 Why?
Disease Progression
5
2017
2630
0.130
 Why?
CTLA-4 Antigen
1
2017
87
0.130
 Why?
fas Receptor
2
2015
95
0.130
 Why?
Biomarkers
2
2019
3968
0.130
 Why?
Sialadenitis
1
2016
2
0.130
 Why?
Antineoplastic Agents
2
2017
2054
0.130
 Why?
Logistic Models
4
2016
1985
0.130
 Why?
Peptidomimetics
1
2016
3
0.130
 Why?
Circulating Tumor DNA
1
2016
28
0.130
 Why?
WT1 Proteins
1
2016
14
0.130
 Why?
Urinary Bladder Neoplasms
1
2019
226
0.130
 Why?
Green Fluorescent Proteins
2
2015
385
0.130
 Why?
Mitogen-Activated Protein Kinases
1
2017
311
0.130
 Why?
HLA-DQ beta-Chains
1
2016
61
0.130
 Why?
Coronary Vessels
2
2017
239
0.130
 Why?
ras GTPase-Activating Proteins
1
2015
15
0.130
 Why?
Peer Group
1
2018
225
0.130
 Why?
Immunoglobulin M
1
2017
276
0.130
 Why?
Immunoglobulin A
1
2017
200
0.130
 Why?
Clonal Evolution
1
2016
39
0.130
 Why?
Transplantation Chimera
1
2016
54
0.120
 Why?
Immunodominant Epitopes
1
2015
28
0.120
 Why?
Molecular Targeted Therapy
1
2019
390
0.120
 Why?
Proto-Oncogene Proteins c-akt
2
2015
431
0.120
 Why?
Psychoanalytic Therapy
1
1995
10
0.120
 Why?
Cesarean Section
1
2017
181
0.120
 Why?
T-Lymphocytes, Helper-Inducer
1
2016
135
0.120
 Why?
RNA, Neoplasm
1
2015
87
0.120
 Why?
Epitopes
2
2015
470
0.120
 Why?
Receptors, HIV
1
2015
25
0.120
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
64
0.120
 Why?
Zinc Fingers
1
2015
45
0.120
 Why?
Psychotherapy, Brief
1
1995
31
0.120
 Why?
Neoplasms, Germ Cell and Embryonal
1
2016
69
0.120
 Why?
Language
1
2018
283
0.120
 Why?
Immunophenotyping
1
2016
310
0.120
 Why?
Sarcoma, Synovial
1
2014
17
0.120
 Why?
Odds Ratio
2
2014
1019
0.120
 Why?
Immunity, Active
1
2014
10
0.120
 Why?
Alphapapillomavirus
1
2015
40
0.120
 Why?
Psychotherapy, Group
1
1995
65
0.120
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
2014
10
0.120
 Why?
Endoribonucleases
1
2015
73
0.120
 Why?
Clinical Trials as Topic
5
2020
1004
0.120
 Why?
Aspirin
1
2018
380
0.110
 Why?
Metalloproteins
1
2014
6
0.110
 Why?
Managed Care Programs
1
1995
133
0.110
 Why?
Clinical Trials, Phase II as Topic
1
2014
72
0.110
 Why?
5' Untranslated Regions
1
2014
55
0.110
 Why?
Hepatitis A Virus Cellular Receptor 2
1
2014
30
0.110
 Why?
Triple Negative Breast Neoplasms
1
2017
197
0.110
 Why?
Nitric Oxide Synthase Type I
1
2014
28
0.110
 Why?
Thrombotic Microangiopathies
1
2014
15
0.110
 Why?
Echocardiography, Stress
1
2013
20
0.110
 Why?
Ribosomal Proteins
1
2014
77
0.110
 Why?
Transcription Factors
2
2019
1647
0.110
 Why?
Tumor Lysis Syndrome
1
2013
8
0.110
 Why?
MAP Kinase Kinase Kinase 5
1
2013
6
0.110
 Why?
Mice, Transgenic
5
2020
2117
0.110
 Why?
Autografts
1
2013
42
0.110
 Why?
Thioredoxins
1
2013
28
0.110
 Why?
Policy Making
1
2014
88
0.110
 Why?
Cross-Sectional Studies
5
2017
5051
0.110
 Why?
HLA-DR4 Antigen
1
2013
78
0.110
 Why?
Testis
1
2014
144
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1049
0.110
 Why?
Extremities
1
2014
127
0.100
 Why?
Motor Skills
1
2014
92
0.100
 Why?
Cognition
2
2023
1122
0.100
 Why?
Health Care Reform
1
2014
101
0.100
 Why?
Immunoglobulin G
1
2017
848
0.100
 Why?
Histones
1
2018
588
0.100
 Why?
Nuclear Proteins
2
2015
659
0.100
 Why?
Allografts
1
2013
136
0.100
 Why?
Transcriptional Activation
1
2015
367
0.100
 Why?
Psychiatric Status Rating Scales
1
2015
528
0.100
 Why?
Astrocytoma
1
2013
115
0.100
 Why?
Gene Expression Regulation, Enzymologic
1
2014
286
0.100
 Why?
Interferon-alpha
1
2014
194
0.100
 Why?
Cell Movement
4
2019
944
0.100
 Why?
Radiation Injuries
1
2014
135
0.100
 Why?
Likelihood Functions
1
2013
137
0.100
 Why?
Infant, Newborn
4
2023
5736
0.100
 Why?
Nanotechnology
1
2013
122
0.100
 Why?
Esophageal Neoplasms
1
2016
295
0.100
 Why?
Risk Factors
5
2023
9746
0.100
 Why?
Survival Rate
4
2020
1869
0.100
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
232
0.100
 Why?
Receptors, N-Methyl-D-Aspartate
1
2014
211
0.100
 Why?
Sarcoma
1
2014
176
0.090
 Why?
Calcinosis
1
2014
231
0.090
 Why?
Muscle Proteins
1
2013
220
0.090
 Why?
Propensity Score
1
2013
263
0.090
 Why?
Cost of Illness
1
2014
277
0.090
 Why?
Killer Cells, Natural
1
2014
427
0.090
 Why?
Anxiety
1
2018
962
0.090
 Why?
Randomized Controlled Trials as Topic
2
2013
1365
0.090
 Why?
Research Design
2
2014
1043
0.090
 Why?
Wounds and Injuries
1
2018
711
0.090
 Why?
Genome, Human
1
2013
392
0.090
 Why?
Health Policy
1
2014
351
0.090
 Why?
Head and Neck Neoplasms
1
2016
543
0.090
 Why?
Xenograft Model Antitumor Assays
3
2020
812
0.090
 Why?
RNA-Binding Proteins
1
2014
387
0.090
 Why?
Cytotoxicity, Immunologic
3
2016
220
0.090
 Why?
Exercise Test
1
2013
612
0.090
 Why?
Genetic Testing
1
2013
428
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2014
947
0.080
 Why?
Decision Support Techniques
1
2013
395
0.080
 Why?
Time Factors
2
2017
6543
0.080
 Why?
Models, Theoretical
1
2013
546
0.080
 Why?
K562 Cells
2
2020
86
0.080
 Why?
Databases, Factual
3
2023
1266
0.080
 Why?
HIV-1
1
2015
837
0.080
 Why?
Adenocarcinoma
1
2016
898
0.080
 Why?
Colorado
2
2017
4406
0.080
 Why?
Protein Kinase Inhibitors
1
2014
890
0.080
 Why?
Coronary Stenosis
1
2008
39
0.070
 Why?
Anti-HIV Agents
1
2015
754
0.070
 Why?
Arthritis, Rheumatoid
1
2017
1097
0.070
 Why?
Comorbidity
3
2018
1544
0.070
 Why?
Double-Blind Method
1
2013
1875
0.070
 Why?
Risk Assessment
2
2014
3233
0.070
 Why?
Apoptosis
2
2013
2499
0.070
 Why?
Neutrophils
1
2013
1207
0.070
 Why?
Neoplasm Transplantation
3
2015
256
0.070
 Why?
RNA, Small Interfering
3
2014
591
0.070
 Why?
Protective Factors
2
2017
91
0.070
 Why?
Mass Screening
2
2020
1149
0.070
 Why?
Faculty
1
2007
137
0.060
 Why?
DNA Mutational Analysis
2
2019
385
0.060
 Why?
Cross Reactions
2
2016
132
0.060
 Why?
Cardiovascular Diseases
1
2018
2003
0.060
 Why?
Molecular Sequence Data
3
2015
2835
0.060
 Why?
Mice, Inbred C57BL
4
2020
5439
0.060
 Why?
CD4 Antigens
2
2016
138
0.060
 Why?
Neutropenia
2
2017
136
0.060
 Why?
Retrospective Studies
5
2024
14461
0.060
 Why?
Mice, Inbred NOD
2
2018
588
0.060
 Why?
Single-Chain Antibodies
2
2015
17
0.060
 Why?
Protein Transport
2
2017
428
0.060
 Why?
Intercellular Junctions
2
2014
39
0.060
 Why?
Physical Examination
2
2017
234
0.060
 Why?
GPI-Linked Proteins
2
2014
68
0.050
 Why?
Parity
1
2024
120
0.050
 Why?
Lung
1
2016
3927
0.050
 Why?
Nerve Tissue Proteins
2
2020
569
0.050
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2023
24
0.050
 Why?
Point Mutation
2
2014
224
0.050
 Why?
Health Facilities
1
2023
79
0.050
 Why?
Autoantigens
2
2016
419
0.050
 Why?
Real-Time Polymerase Chain Reaction
2
2013
328
0.050
 Why?
Bone Marrow
1
2023
271
0.050
 Why?
Minority Groups
1
2024
249
0.050
 Why?
Receptors, Cell Surface
1
2004
380
0.050
 Why?
Cluster Analysis
2
2014
479
0.050
 Why?
Linear Models
1
2024
819
0.050
 Why?
Alleles
2
2015
845
0.050
 Why?
Skin
2
2019
726
0.050
 Why?
Severity of Illness Index
2
2023
2740
0.050
 Why?
Oligonucleotide Array Sequence Analysis
2
2014
756
0.050
 Why?
Educational Status
1
2023
469
0.040
 Why?
Proportional Hazards Models
1
2024
1197
0.040
 Why?
Recombinant Proteins
2
2014
1304
0.040
 Why?
Parenting
1
2024
294
0.040
 Why?
Predictive Value of Tests
2
2017
1949
0.040
 Why?
Models, Genetic
2
2013
593
0.040
 Why?
Glioma
1
2004
347
0.040
 Why?
Jurkat Cells
1
2020
134
0.040
 Why?
Immunoglobulins
1
2020
160
0.040
 Why?
Base Sequence
2
2014
2146
0.040
 Why?
Cysteine Endopeptidases
1
2020
68
0.040
 Why?
Caregivers
2
2018
809
0.040
 Why?
Early Diagnosis
1
2020
233
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2019
69
0.040
 Why?
Health Care Surveys
1
2021
557
0.040
 Why?
Hydrolysis
1
2019
186
0.040
 Why?
GTP Phosphohydrolases
1
2019
85
0.040
 Why?
Fusion Regulatory Protein 1, Heavy Chain
1
2018
2
0.040
 Why?
Protein Domains
1
2020
253
0.040
 Why?
Forests
1
2018
58
0.040
 Why?
Cervix Uteri
1
2018
49
0.040
 Why?
GTP-Binding Protein alpha Subunits, Gi-Go
1
2018
18
0.040
 Why?
Healthcare Disparities
1
2024
575
0.040
 Why?
Nuclear Localization Signals
1
2017
15
0.040
 Why?
Uterine Cervical Dysplasia
1
2018
42
0.040
 Why?
Mice, SCID
1
2018
350
0.040
 Why?
Hydrogen Bonding
1
2018
149
0.040
 Why?
Disulfides
1
2018
97
0.040
 Why?
Platelet Aggregation
1
2018
95
0.030
 Why?
Ligands
2
2013
621
0.030
 Why?
Eye Enucleation
1
2017
11
0.030
 Why?
Human papillomavirus 18
1
2017
15
0.030
 Why?
Response Evaluation Criteria in Solid Tumors
1
2017
16
0.030
 Why?
Protein Stability
1
2018
162
0.030
 Why?
GTP-Binding Protein alpha Subunits
1
2017
14
0.030
 Why?
GTP-Binding Protein alpha Subunits, Gq-G11
1
2017
19
0.030
 Why?
Culture Media, Serum-Free
1
2016
49
0.030
 Why?
Lymphopenia
1
2017
60
0.030
 Why?
Binding Sites
1
2020
1250
0.030
 Why?
Peptide Fragments
2
2015
692
0.030
 Why?
Vaccinia virus
1
2016
42
0.030
 Why?
Drug Synergism
1
2017
370
0.030
 Why?
Antigen-Presenting Cells
1
2017
151
0.030
 Why?
HLA-DRB1 Chains
1
2017
108
0.030
 Why?
Adenosine Triphosphate
1
2019
478
0.030
 Why?
Blood Chemical Analysis
1
2017
96
0.030
 Why?
Asymptomatic Diseases
1
2017
84
0.030
 Why?
Salivary Glands, Minor
1
2016
9
0.030
 Why?
Tissue Array Analysis
1
2016
57
0.030
 Why?
Health Surveys
1
2018
493
0.030
 Why?
Radiotherapy
1
2017
185
0.030
 Why?
Neoplasm Invasiveness
1
2018
483
0.030
 Why?
Machine Learning
1
2021
442
0.030
 Why?
Cell Membrane
1
2020
733
0.030
 Why?
Leukemia, B-Cell
1
2016
13
0.030
 Why?
Feasibility Studies
1
2020
867
0.030
 Why?
Palate
1
2016
35
0.030
 Why?
Fas Ligand Protein
1
2015
59
0.030
 Why?
HLA-A1 Antigen
1
2015
4
0.030
 Why?
Antigen-Antibody Reactions
1
2015
52
0.030
 Why?
Genes, erbB-2
1
2015
28
0.030
 Why?
Health Promotion
1
2022
719
0.030
 Why?
Anemia
1
2017
160
0.030
 Why?
Salvage Therapy
1
2016
133
0.030
 Why?
MAP Kinase Signaling System
1
2017
313
0.030
 Why?
Anus Neoplasms
1
2015
30
0.030
 Why?
Interferon-gamma Release Tests
1
2015
32
0.030
 Why?
Compulsive Behavior
1
2015
7
0.030
 Why?
Gastrointestinal Diseases
1
2017
198
0.030
 Why?
Necrosis
1
2016
232
0.030
 Why?
Thrombocytopenia
1
2017
186
0.030
 Why?
DNA, Neoplasm
1
2015
158
0.030
 Why?
HIV Envelope Protein gp120
1
2015
57
0.030
 Why?
Cloning, Molecular
1
2016
525
0.030
 Why?
Dermatitis
1
2014
19
0.030
 Why?
HIV Antibodies
1
2015
57
0.030
 Why?
Protein Conformation
1
2018
861
0.030
 Why?
Income
1
2016
188
0.030
 Why?
Desmoplakins
1
2014
19
0.030
 Why?
Regression Analysis
1
2017
991
0.030
 Why?
Metabolic Clearance Rate
1
2014
117
0.030
 Why?
Transplantation, Homologous
1
2016
400
0.030
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2015
147
0.030
 Why?
Cell Survival
1
2017
1075
0.030
 Why?
Models, Statistical
1
2018
623
0.030
 Why?
Monophenol Monooxygenase
1
2014
8
0.030
 Why?
Nausea
1
2014
110
0.030
 Why?
Comparative Genomic Hybridization
1
2014
32
0.030
 Why?
Gene Library
1
2014
115
0.030
 Why?
Mice, Inbred BALB C
1
2017
1247
0.030
 Why?
Sleep Wake Disorders
1
2017
251
0.030
 Why?
National Institutes of Health (U.S.)
1
2014
122
0.030
 Why?
Random Allocation
1
2014
346
0.030
 Why?
MAP Kinase Kinase 4
1
2013
28
0.030
 Why?
Social Class
1
2016
258
0.030
 Why?
Substrate Specificity
1
2014
368
0.030
 Why?
Histocompatibility Antigens
1
2014
107
0.030
 Why?
Infusions, Intravenous
1
2014
399
0.030
 Why?
Health Services Accessibility
1
2021
899
0.030
 Why?
Graft vs Host Disease
1
2016
240
0.030
 Why?
Tumor Burden
1
2014
286
0.030
 Why?
X-Ray Diffraction
1
2013
94
0.030
 Why?
Radiotherapy, Adjuvant
1
2014
208
0.030
 Why?
Lentivirus
1
2013
53
0.030
 Why?
Confidence Intervals
1
2014
316
0.030
 Why?
Structure-Activity Relationship
1
2014
548
0.030
 Why?
Fever
1
2014
298
0.030
 Why?
Immunoenzyme Techniques
1
2013
214
0.030
 Why?
Immunoprecipitation
1
2013
157
0.030
 Why?
Reproducibility of Results
2
2012
3080
0.030
 Why?
Models, Molecular
1
2018
1487
0.030
 Why?
Bias
1
2013
196
0.020
 Why?
Drug Administration Schedule
1
2014
768
0.020
 Why?
Cost-Benefit Analysis
1
1995
569
0.020
 Why?
Histocompatibility Antigens Class II
1
2014
363
0.020
 Why?
DNA Primers
1
2013
510
0.020
 Why?
Cotinine
1
2012
75
0.020
 Why?
Receptors, Immunologic
1
2013
216
0.020
 Why?
Spleen
1
2014
506
0.020
 Why?
Liver Neoplasms
1
2017
640
0.020
 Why?
Bayes Theorem
1
2013
373
0.020
 Why?
Pregnancy
1
2023
6391
0.020
 Why?
Blotting, Western
1
2013
1204
0.020
 Why?
Carrier Proteins
1
2014
742
0.020
 Why?
Multivariate Analysis
1
2014
1497
0.020
 Why?
Aged, 80 and over
2
2014
7055
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
2011
0.020
 Why?
Kinetics
1
2013
1644
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2015
1202
0.020
 Why?
Phosphorylation
1
2014
1710
0.020
 Why?
Infant, Premature
1
2014
541
0.020
 Why?
North Carolina
1
2008
98
0.020
 Why?
Germany
1
2008
100
0.020
 Why?
Self Report
1
2012
795
0.020
 Why?
Cell Differentiation
1
2015
1887
0.020
 Why?
Education of Intellectually Disabled
1
1987
3
0.020
 Why?
Disease Models, Animal
1
2018
4057
0.020
 Why?
Vaccination
1
2016
1347
0.020
 Why?
Models, Biological
1
2014
1722
0.020
 Why?
MicroRNAs
1
2013
676
0.020
 Why?
Intelligence
1
2007
130
0.020
 Why?
Polymorphism, Single Nucleotide
1
2013
2063
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2004
15
0.010
 Why?
Urokinase-Type Plasminogen Activator
1
2004
29
0.010
 Why?
Transplantation, Heterologous
1
2004
192
0.010
 Why?
Species Specificity
1
2004
574
0.010
 Why?
Mice, Nude
1
2004
682
0.010
 Why?
Neovascularization, Pathologic
1
2004
296
0.010
 Why?
Down Syndrome
1
1987
477
0.010
 Why?
Polyethylene Glycols
1
2004
587
0.010
 Why?
Endothelium, Vascular
1
2004
901
0.010
 Why?
Rosenberg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (590) concept(s)
_
Co-Authors Expand Description
See all (10) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)